+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Urinary Tract Infection Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Class, Indication, Distribution Channel, and Geography

  • ID: 5237921
  • Report
  • November 2020
  • Region: Global
  • 241 Pages
  • The Insight Partners
UP TO OFF
until Jun 30th 2022

FEATURED COMPANIES

  • ALLERGAN
  • Amway
  • Cipla Ltd
  • F. Hoffmann-La Roche Ltd
  • Mylan N.V.
  • Pfizer Inc.
Market for Penicillin and Combination Drugs Segment to Grow at Highest CAGR during 2020-2027.

According to the new market research study on “Urinary Tract Infection Treatment Market to 2027 - COVID-19 Impact and Global Analysis - by Drug Class, Indication, and Distribution Channel,” the market is expected to reach US$ 11,614.32 million by 2027 from US$ 9,106.40 million in 2019; it is estimated to grow at a CAGR of 3.2% from 2020 to 2027. The growth of the market is attributed to the growing prevalence of urinary tract infections, aging population, and emerging computing technologies for urine diagnostics. However, the lack of product awareness in emerging countries and effects associated with medication obstruct the growth of the market to a certain extent.

Based on drug class, the quinolones segment held the largest share of the market in 2019; however, the penicillin and combination segment is anticipated to register the highest CAGR of 4.5% in the market during the forecast period. The future growth of the market for quinolones is mainly ascribed to the fact that it is most commonly prescribed by physicians. Ciprofloxacin, levofloxacin, and enoxacin are among the most widely used drugs for treatment.

R& D in UTI treatment is expected to offer lucrative growth opportunities to the players in the global urinary tract infection treatment market. For instance, in July 2018, Lupin received approval from the US Food and Drug Administration (FDA) for generic Nitrofurantoin capsules. It is a generic version of Macrodantin offered by Alvogen Malta Operations Ltd. It is used to treat UTI caused by Staphylococcus aureus, enterococci, etc. Further, in February 2020, a France-based pharmaceutical company announced Exblifep, a combination of a novel extended-spectrum beta-lactamase inhibitor, enmetazobactam, and cefepime. i.e., the fourth-generation cephalosporin, which achieved primary endpoints in a clinical trial for complicated UTIs. Moreover, in July 2019, Healthy.io, a smartphone camera-based solutions developer, announced an agreement with Walgreens Boots Alliance, Inc. placing Healthy.io's Dip UTI test kits in boots pharmacies throughout the UK. Additionally, in May 2020, Spero Therapeutics, Inc. announced the completion of patient enrollment in its Phase 3 clinical trial, ADAPT-PO, of tebipenem HBr to treat complicated urinary tract infection (cUTI) and acute pyelonephritis (AP). In July 2019, the US FDA approved Recarbrio drug to treat cUTI and complicated intra-abdominal infection in adults. In June 2018, Achaogen, Inc. received the US FDA approval for ZEMDRI to treat cUTIs in adults. In November 2018, Allergan, announced the launch of the FDA accepted supplemental drug AVYCAZ to treat cUTIs and complicated intra-abdominal infections patients between the age group of 3 months to 18 years. Applying such strategic measures can be lucrative for the urinary tract infection treatment market during the forecast period.

The COVID-19 pandemic was first reported in December 2019 in Wuhan (China). The impacts of this outbreak are being felt across several markets in the world. The demand for urinary tract infection treatment solutions has reduced amid this global crisis due to a significant shift in the focus toward the management, treatment, and prevention of COVID-19.

Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Mylan N.V., ALLERGAN, Pfizer Inc., Cipla Ltd, F. Hoffmann-La Roche Ltd, Shionogi Inc., Amway, and DuPont Nutrition & Biosciences are among the leading companies in the urinary tract infection treatment market.

The Report Segments Urinary Tract Infection Treatment Market as Follows:

By Drug Class
  • Penicillin and Combinations
  • Quinolones
  • Cephalosporin
  • Aminoglycoside Antibiotics
  • Sulphonamides
  • Nutritional Supplements

By Indication
  • Complicated Urinary Tract Infection
  • Uncomplicated Urinary Tract Infection

By Distribution Channel
  • Hospital Pharmacies
  • Gynaecology and Urology Clinics
  • Retail Pharmacies and Drug Store
  • Online Drug Stores

By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
  • Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • South and Central America (SCAM)
  • Brazil
  • Argentina


Reasons to Buy:
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the urinary tract infection treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global urinary tract infection treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ALLERGAN
  • Amway
  • Cipla Ltd
  • F. Hoffmann-La Roche Ltd
  • Mylan N.V.
  • Pfizer Inc.
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Urinary Tract Infection Treatment Market - By Drug Class
1.3.2 Global Urinary Tract Infection Treatment Market - By Indication
1.3.3 Global Urinary Tract Infection Treatment Market - By Distribution Channel
1.3.4 Global Urinary Tract Infection Treatment Market - By Geography

2. Urinary Tract Infection Treatment Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Urinary Tract Infection Treatment Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East & Africa
4.2.5 South & Central America
4.3 Expert Opinion

5. Urinary Tract Infection Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Urinary Tract Infections
5.1.2 Aging Population
5.1.3 Emerging Computing Technologies for Urine Diagnostics
5.2 Market Restraints
5.2.1 Associated Effects of Medication
5.3 Market Opportunities
5.3.1 R&D in UTI Treatment
5.4 Future Trends
5.4.1 Nutritional Supplement in UTI
5.5 Impact Analysis

6. Urinary Tract Infection Treatment Market - Global Analysis
6.1 Global Urinary Tract Infection Treatment Market Revenue Forecast and Analysis
6.2 Global Urinary Tract Infection Treatment Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Urinary Tract Infection Treatment Market Analysis - By Drug Class
7.1 Overview
7.2 Urinary Tract Infection Treatment Market Revenue Share, by Drug Class (2019 and 2027)
7.3 Penicillin and Combinations
7.3.1 Overview
7.3.2 Penicillin and Combinations: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.3.3 Amoxicillin
7.3.3.1 Overview
7.3.3.2 Amoxicillin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.3.4 Amoxicillin and Clavulanate Potassium
7.3.4.1 Overview
7.3.4.2 Amoxicillin and Clavulanate Potassium: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.3.5 Others
7.3.5.1 Overview
7.3.5.2 Others: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Quinolones
7.4.1 Overview
7.4.2 Quinolones: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3 Ciprofloxaxin
7.4.3.1 Overview
7.4.3.2 Ciprofloxaxin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.4.4 Levofloxaxin
7.4.4.1 Overview
7.4.4.2 Levofloxaxin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.4.5 Nalidixic Acid
7.4.5.1 Overview
7.4.5.2 Nalidixic Acid: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.4.6 Norfloxacin
7.4.6.1 Overview
7.4.6.2 Norfloxacin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.4.7 Others
7.4.7.1 Overview
7.4.7.2 Others: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Cephalosporin
7.5.1 Overview
7.5.2 Cephalosporin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Aminoglycoside Antibiotics
7.6.1 Overview
7.6.2 Aminoglycoside Antibiotics: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.7 Sulphonamides
7.7.1 Overview
7.7.2 Sulphonamides: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.8 Nutritional Supplements
7.8.1 Overview
7.8.2 Nutritional Supplements: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.8.3 Cranberry Supplements
7.8.3.1 Overview
7.8.3.2 Cranberry Supplements: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.8.4 D-Mannose
7.8.4.1 Overview
7.8.4.2 D-Mannose: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.8.5 Probiotics
7.8.5.1 Overview
7.8.5.2 Probiotics: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.8.6 Vitamin-C
7.8.6.1 Overview
7.8.6.2 Vitamin-C: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.8.7 Others
7.8.7.1 Overview
7.8.7.2 Others: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)

8. Urinary Tract Infection Treatment Market Analysis - By Indication
8.1 Overview
8.2 Urinary Tract Infection Treatment Market Revenue Share, by Indication (2019 and 2027)
8.3 Complicated Urinary Tract Infections
8.3.1 Overview
8.3.2 Complicated Urinary Tract Infections: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Uncomplicated Urinary Tract Infections
8.4.1 Overview
8.4.2 Uncomplicated Urinary Tract Infections: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)

9. Urinary Tract Infection Treatment Market Analysis - By Distribution Channel
9.1 Overview
9.2 Urinary Tract Infection Treatment Market Revenue Share, by Distribution Channel (2019 and 2027)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Retail Pharmacies & Drug Stores
9.4.1 Overview
9.4.2 Retail Pharmacies: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Gynaecology and Urology Clinics
9.5.1 Overview
9.5.2 Gynaecology and Urology Clinics: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
9.6 Online Drug Stores
9.6.1 Overview
9.6.2 Online Drug Stores: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)

10. Urinary Tract Infection Treatment Market - Geographic Analysis
10.1 North America: Urinary Tract Infection Treatment Market
10.1.1 Overview
10.1.2 North America: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.1.3.1 North America: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.3.2 North America: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.3.3 North America: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.4 North America: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.1.5 North America: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Urinary Tract Infection Treatment Market, by Country, 2019 & 2027 (%)
10.1.7 US: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.1.7.2.1 US: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.2.2 US: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.2.3 US: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.1.8.2.1 Canada: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.2.2 Canada: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.2.3 Canada: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.1.9.2.1 Mexico: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.2.2 Mexico: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.2.3 Mexico: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2 Europe: Urinary Tract Infection Treatment Market
10.2.1 Overview
10.2.2 Europe: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.2.3.1 Europe: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.3.2 Europe: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.3.3 Europe: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.4 Europe: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.2.5 Europe: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.6 Europe: Urinary Tract Infection Treatment Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.2.7.2.1 Germany: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.7.2.2 Germany: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.7.2.3 Germany: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.7.3 Germany: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.2.7.4 Germany: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.8 UK: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.2.8.2.1 UK: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.8.2.2 UK: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.8.2.3 UK: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.8.3 UK: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.2.8.4 UK: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.9 France: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.2.9.2.1 France: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.9.2.2 France: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.9.2.3 France: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.9.3 France: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.2.9.4 France: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.10 Spain: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.2.10.2.1 Spain: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.10.2.2 Spain: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.10.2.3 Spain: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.10.3 Spain: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.2.10.4 Spain: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.11 Italy: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.2.11.2.1 Italy: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.11.2.2 Italy: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.11.2.3 Italy: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.11.3 Italy: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.2.11.4 Italy: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.12 Rest of Europe: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.2.12.1 Rest of Europe: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.2.12.2 Rest of Europe: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.2.12.2.1 Rest of Europe: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.12.2.2 Rest of Europe: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.12.2.3 Rest of Europe: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.12.3 Rest of Europe: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.2.12.4 Rest of Europe: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3 Asia Pacific: Urinary Tract Infection Treatment Market
10.3.1 Overview
10.3.2 Asia Pacific: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia-Pacific: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.3.3.1 Asia-Pacific: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.3.2 Asia-Pacific: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.3.3 Asia-Pacific: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.4 Asia-Pacific: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.3.5 Asia-Pacific: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.6 Asia Pacific: Urinary Tract Infection Treatment Market, by Country, 2019 & 2027 (%)
10.3.7 China: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.3.7.3 China: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.3.7.3.1 China: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.7.3.2 China: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.7.3.3 China: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.7.4 China: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.3.7.5 China: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.8 Japan: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.3.8.2.1 Japan: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.8.2.2 Japan: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.8.2.3 Japan: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.8.3 Japan: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.3.8.4 Japan: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.9 India: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.3.9.2.1 India: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.9.2.2 India: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.9.2.3 India: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.9.3 India: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.3.9.4 India: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.10 South Korea: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.3.10.2.1 South Korea: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.10.2.2 South Korea: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.10.2.3 South Korea: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.10.3 South Korea: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.3.10.4 South Korea: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.11 Australia: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.3.11.2.1 Australia: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.11.2.2 Australia: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.11.2.3 Australia: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.11.3 Australia: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.3.11.4 Australia: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.12 Rest of Asia-Pacific: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.3.12.1 Rest of Asia-Pacific: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.3.12.2 Rest of Asia-Pacific: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.3.12.2.1 Rest of Asia-Pacific: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.12.2.2 Rest of Asia-Pacific: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.12.2.3 Rest of Asia-Pacific: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.12.3 Rest of Asia-Pacific: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.3.12.4 Rest of Asia-Pacific: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4 Middle East & Africa: Urinary Tract Infection Treatment Market
10.4.1 Overview
10.4.2 Middle East & Africa: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East and Africa: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.4.3.1 Middle East and Africa: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.3.2 Middle East and Africa: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.3.3 Middle East and Africa: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.4 Middle East and Africa: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.4.5 Middle East and Africa: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4.6 Middle East & Africa: Urinary Tract Infection Treatment Market, by Country, 2018 & 2027 (%)
10.4.7 Saudi Arabia: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.4.7.2.1 Saudi Arabia: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.7.2.2 Saudi Arabia: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.7.2.3 Saudi Arabia: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.7.3 Saudi Arabia: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.4.7.4 Saudi Arabia: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4.8 UAE: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.4.8.2.1 UAE: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.8.2.2 UAE: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.8.2.3 UAE: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.8.3 UAE: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.4.8.4 UAE: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4.9 South Africa: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.4.9.2.1 South Africa: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.9.2.2 South Africa: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.9.2.3 South Africa: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.9.3 South Africa: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.4.9.4 South Africa: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4.10 Rest of Middle East and Africa: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.4.10.1 Rest of Middle East and Africa: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.4.10.2 Rest of Middle East and Africa: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.4.10.2.1 Rest of Middle East and Africa: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.10.2.2 Rest of Middle East and Africa: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.10.2.3 Rest of Middle East and Africa: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.10.3 Rest of Middle East and Africa: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.4.10.4 Rest of Middle East and Africa: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.5 South and Central America: Urinary Tract Infection Treatment Market
10.5.1 Overview
10.5.2 South and Central America: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.5.3 South and Central America: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.5.3.1 South and Central America: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.3.2 South and Central America: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.3.3 South and Central America: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.4 South and Central America: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.5.5 South and Central America: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.5.6 South and Central America: Urinary Tract Infection Treatment Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.5.7.2.1 Brazil: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.7.2.2 Brazil: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.7.2.3 Brazil: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.7.3 Brazil: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.5.7.4 Brazil: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.5.8 Argentina: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.5.8.2.1 Argentina: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.8.2.2 Argentina: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.8.2.3 Argentina: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.8.3 Argentina: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.5.8.4 Argentina: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.5.9 Rest of South and Central America: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.5.9.1 Rest of South and Central America: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
10.5.9.2 Rest of South and Central America: Urinary Tract Infection Treatment Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.5.9.2.1 Rest of South and Central America: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.9.2.2 Rest of South and Central America: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.9.2.3 Rest of South and Central America: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.9.3 Rest of South and Central America: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
10.5.9.4 Rest of South and Central America: Urinary Tract Infection Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on Global Urinary Tract Infection Treatment Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Urinary Tract Infection Treatment Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview

List of Tables
Table 1. North America: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 2. North America: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 3. North America: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 4. North America: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 5. North America: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 6. North America: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 7. US: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 8. US: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 9. US: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 10. US: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 11. US: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 12. US: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 13. Canada: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 14. Canada: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 15. Canada: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 16. Canada: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 17. Canada: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 18. Canada: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 19. Mexico: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 20. Mexico: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 21. Mexico: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 22. Mexico: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 23. Mexico: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 24. Mexico: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 25. Europe: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 26. Europe: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 27. Europe: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 28. Europe: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 29. Europe: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 30. Europe: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 31. Germany: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 32. Germany: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 33. Germany: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 34. Germany: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 35. Germany: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 36. Germany: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 37. UK: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 38. UK: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 39. UK: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 40. UK: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 41. UK: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 42. UK: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 43. France: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 44. France: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 45. France: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 46. France: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 47. France: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 48. France: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 49. Spain: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 50. Spain: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 51. Spain: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 52. Spain: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 53. Spain: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 54. Spain: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 55. Italy: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 56. Italy: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 57. Italy: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 58. Italy: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 59. Italy: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 60. Italy: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 61. Rest of Europe: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 62. Rest of Europe: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 63. Rest of Europe: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 64. Rest of Europe: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 65. Rest of Europe: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 66. Rest of Europe: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 67. Asia-Pacific: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 68. Asia-Pacific: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 69. Asia-Pacific: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 70. Asia-Pacific: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 71. Asia-Pacific: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 72. Asia-Pacific: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 73. China: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 74. China: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 75. China: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 76. China: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 77. China: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 78. China: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 79. Japan: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 80. Japan: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 81. Japan: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 82. Japan: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 83. Japan: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 84. Japan: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 85. India: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 86. India: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 87. India: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 88. India: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 89. India: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 90. India: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 91. South Korea: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 92. South Korea: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 93. South Korea: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 94. South Korea: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 95. South Korea: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 96. South Korea: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 97. Australia: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 98. Australia: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 99. Australia: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 100. Australia: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 101. Australia: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 102. Australia: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 103. Rest of Asia-Pacific: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 104. Rest of Asia-Pacific: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 105. Rest of Asia-Pacific: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 106. Rest of Asia-Pacific: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 107. Rest of Asia-Pacific: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 108. Rest of Asia-Pacific: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 109. Middle East and Africa: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 110. Middle East and Africa: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 111. Middle East and Africa: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 112. Middle East and Africa: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 113. Middle East and Africa: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 114. Middle East and Africa: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 115. Saudi Arabia: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 116. Saudi Arabia: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 117. Saudi Arabia: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 118. Saudi Arabia: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 119. Saudi Arabia: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 120. Saudi Arabia: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 121. UAE: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 122. UAE: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 123. UAE: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 124. UAE: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 125. UAE: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 126. UAE: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 127. South Africa: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 128. South Africa: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 129. South Africa: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 130. South Africa: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 131. South Africa: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 132. South Africa: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 133. Rest of Middle East and Africa: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 134. Rest of Middle East and Africa: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 135. Rest of Middle East and Africa: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 136. Rest of Middle East and Africa: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 137. Rest of Middle East and Africa: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 138. Rest of Middle East and Africa: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 139. South and Central America: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 140. South and Central America: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 141. South and Central America: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 142. South and Central America: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 143. South and Central America: Urinary Tract Infection Treatment Market, by Indication- Revenue and Forecast to 2027 (USD Million)
Table 144. South and Central America: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 145. Brazil: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 146. Brazil: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 147. Brazil: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 148. Brazil: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 149. Brazil: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 150. Brazil: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 151. Argentina: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 152. Argentina: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 153. Argentina: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 154. Argentina: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 155. Argentina: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 156. Argentina: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 157. Rest of South and Central America: Urinary Tract Infection Treatment Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 158. Rest of South and Central America: Penicillin and Combination Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 159. Rest of South and Central America: Quinolones Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 160. Rest of South and Central America: Nutritional Supplements Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 161. Rest of South and Central America: Urinary Tract Infection Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 162. Rest of South and Central America: Urinary Tract Infection Treatment Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 163. Organic Developments Done By Companies
Table 164. Inorganic Developments Done By Companies
Table 165. Glossary of Terms, Urinary Tract Infection Treatment Market


List of Figures
Figure 1. Urinary Tract Infection Treatment Market Segmentation
Figure 2. Urinary Tract Infection Treatment Segmentation, By Region
Figure 3. Global Urinary Tract Infection Treatment Market Overview
Figure 4. Quinolones Segment Held Largest Share of Urinary Tract Infection Treatment Market
Figure 5. APAC to Show Remarkable Growth During Forecast Period
Figure 6. Global Urinary Tract Infection Treatment Market, by Geography (US$ Million)
Figure 7. Global Urinary Tract Infection Treatment Market - Leading Country Markets (US$ Million)
Figure 8. Global Urinary Tract Infection Treatment Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Expert Opinion
Figure 15. Urinary Tract Infection Treatments Market Impact Analysis of Drivers and Restraints
Figure 16. Global Urinary Tract Infection Treatment Market - Revenue Forecast and Analysis - 2019- 2027
Figure 17. Global Urinary Tract Infection Treatment Market - By Geography Forecast and Analysis - 2019- 2027
Figure 18. Market Positioning of Key Players in Global Urinary Tract Infection Treatment Market
Figure 19. Urinary Tract Infection Treatment Market Revenue Share, by Drug Class (2019 and 2027)
Figure 20. Penicillin and Combinations: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Amoxicillin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Amoxicillin and Clavulanate Potassium: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Others: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Quinolones: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Ciprofloxaxin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Levofloxaxin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Nalidixic Acid: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 28. Norfloxacin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 29. Others: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 30. Cephalosporin: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 31. Aminoglycoside Antibiotics: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 32. Sulphonamides: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 33. Nutritional Supplements: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 34. Cranberry Supplements: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 35. D-Mannose: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 36. Probiotics: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 37. Vitamin-C: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 38. Others: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 39. Urinary Tract Infection Treatment Market Revenue Share, by Indication (2019 and 2027)
Figure 40. Complicated Urinary Tract Infections: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 41. Uncomplicated Urinary Tract Infections: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 42. Urinary Tract Infection Treatment Market Revenue Share, by Drug Class (2019 and 2027)
Figure 43. Hospital Pharmacies: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 44. Retail Pharmacies & Drug Store: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 45. Gynaecology and Urology Clinics: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 46. Online Drug Stores: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (US$ Million)
Figure 47. North America: Urinary Tract Infection Treatment Market, by Key Country - Revenue (2019) (USD Million)
Figure 48. North America Urinary Tract Infection Treatment Market Revenue and Forecast to 2027 (USD Million)
Figure 49. North America: Urinary Tract Infection Treatment Market, by Country, 2019 & 2027 (%)
Figure 50. US: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 51. Canada: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 52. Mexico: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 53. Europe: Urinary Tract Infection Treatment Market, by Key Country - Revenue (2019) (USD Million)
Figure 54. Europe Urinary Tract Infection Treatment Market Revenue and Forecast to 2027 (USD Million)
Figure 55. Europe: Urinary Tract Infection Treatment Market, by Country, 2019 & 2027 (%)
Figure 56. Germany: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 57. UK: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 58. France: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 59. Spain: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 60. Italy: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 61. Rest of Europe: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 62. Asia Pacific: Urinary Tract Infection Treatment Market, by Key Country - Revenue (2019) (USD Million)
Figure 63. Asia Pacific Urinary Tract Infection Treatment Market Revenue and Forecast to 2027 (USD Million)
Figure 64. Asia Pacific: Urinary Tract Infection Treatment Market, by Country, 2019 & 2027 (%)
Figure 65. China: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 66. Japan: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 67. India: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 68. South Korea: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 69. Australia: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 70. Rest of Asia-Pacific: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 71. Middle East & Africa: Urinary Tract Infection Treatment Market, by Key Country - Revenue (2019) (USD Million)
Figure 72. Middle East & Africa Urinary Tract Infection Treatment Market Revenue and Forecast to 2027 (USD Million)
Figure 73. Middle East & Africa: Urinary Tract Infection Treatment Market, by Country, 2018 & 2027 (%)
Figure 74. Saudi Arabia: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 75. UAE: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 76. South Africa: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 77. Rest of Middle East and Africa: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 78. South and Central America: Urinary Tract Infection Treatment Market, by Key Country - Revenue (2019) (USD Million)
Figure 79. South and Central America Urinary Tract Infection Treatment Market Revenue and Forecast to 2027 (USD Million)
Figure 80. South and Central America: Urinary Tract Infection Treatment Market, by Country, 2019 & 2027 (%)
Figure 81. Brazil: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 82. Argentina: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 83. Rest of South and Central America: Urinary Tract Infection Treatment Market - Revenue and Forecast to 2027 (USD Million)
Figure 84. Impact of COVID-19 Pandemic in North American Country Markets
Figure 85. Impact of COVID-19 Pandemic in European Country Markets
Figure 86. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 87. Impact of COVID-19 Pandemic in North American Country Market
Figure 88. Growth Strategies Done by the Companies in the Market, (%)
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • Mylan N.V.
  • ALLERGAN
  • Pfizer Inc.
  • Cipla Ltd
  • F. Hoffmann-La Roche Ltd
  • Shionogi Inc.
  • Amway
  • DuPont Nutrition & Biosciences
Note: Product cover images may vary from those shown